These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25645989)

  • 21. Factors affecting the natural decay of hepatitis B surface antigen in children with chronic hepatitis B virus infection during long-term follow-up.
    Chiu YC; Liao SF; Wu JF; Lin CY; Lee WC; Chen HL; Ni YH; Hsu HY; Chang MH
    J Pediatr; 2014 Oct; 165(4):767-72.e1. PubMed ID: 25112693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
    Arai M; Togo S; Kanda T; Fujiwara K; Imazeki F; Yokosuka O
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):414-8. PubMed ID: 22273987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years].
    Sun Y; Chen TY; Lu PX; Wang JB; Wu Y; Zhang QN; Qian GS; Tu H
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1874-7. PubMed ID: 23134955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers.
    Larsson SB; Eilard A; Malmström S; Hannoun C; Dhillon AP; Norkrans G; Lindh M
    Liver Int; 2014 Aug; 34(7):e238-45. PubMed ID: 24118747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
    Jaroszewicz J; Calle Serrano B; Wursthorn K; Deterding K; Schlue J; Raupach R; Flisiak R; Bock CT; Manns MP; Wedemeyer H; Cornberg M
    J Hepatol; 2010 Apr; 52(4):514-22. PubMed ID: 20207438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
    Chen J; Wang Z; Zhou B; Wang Y; Hou J
    Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.
    Seto WK; Wong DK; Fung J; Huang FY; Liu KS; Lai CL; Yuen MF
    Clin Microbiol Infect; 2014 Nov; 20(11):1173-80. PubMed ID: 24975365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.
    Su CW; Wu CY; Hung HH; Wu CH; Sheen IJ; Wu JC
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1849-58. PubMed ID: 23730852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?
    Sali S; Sharafi H; Alavian SH; Alavian SM; Etesam F; Salimi S; Merza MA; Keshvari M
    Diagn Microbiol Infect Dis; 2015 Jun; 82(2):114-9. PubMed ID: 25863529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study.
    Gupta E; Kumar A; Choudhary A; Kumar M; Sarin SK
    Indian J Med Microbiol; 2012; 30(2):150-4. PubMed ID: 22664428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
    Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
    Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients.
    Arendt E; Jaroszewicz J; Rockstroh J; Meyer-Olson D; Zacher BJ; Mederacke I; Manns MP; Wedemeyer H; Cornberg M; Wursthorn K
    Viral Immunol; 2012 Dec; 25(6):442-7. PubMed ID: 23131018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiviral nucleotide-induced dynamic change of HBV DNA and HBsAg and significance of quarterly and annual quantitative measurements over 5-year follow-up of chronic hepatitis B patients].
    Xi HL; Li MR; Bao Y; Yu M; Qin XQ; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):821-4. PubMed ID: 24331690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
    Lin LY; Wong VW; Zhou HJ; Chan HY; Gui HL; Guo SM; Wang H; Huang L; Bao SS; Xie Q; Chan HL
    J Med Virol; 2010 Sep; 82(9):1494-500. PubMed ID: 20648602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
    Ungtrakul T; Sriprayoon T; Kusuman P; Chunnuan P; Soonklang K; Sornsamdang G; Auewarakul CU; Tanwandee T
    Medicine (Baltimore); 2017 Mar; 96(13):e6554. PubMed ID: 28353619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
    J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.